Avelas Biosciences Secures $7,650,000 Series A Funding
-
Feed Type
-
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=3c89042f-0781-48f3-9d25-d74f212f05e2&Preview=1 -
Date
12/7/2012 -
Company Name
Avelas Biosciences -
Mailing Address
11099 N. Torrey Pines Road La Jolla, CA 92037 -
Company Description
At Avelas Biosciences, our mission is to advance a new standard-of-care in cancer surgery by providing a real time luminous map for oncologic surgeons, leading to improved surgical results and better outcome for patients. -
Website
http://www.avelasbio.com -
Transaction Type
Venture Equity -
Transaction Amount
$7,650,000 -
Transaction Round
Series A -
Proceeds Purposes
Avelas will use the funding to advance the Avelas Cancer Illuminator (ACI) towards clinical studies for the visualization of cancerous lymph nodes in breast cancer patients. -
M&A Terms
-
Venture Investor
Avalon Ventures
